Collateral for a security interest recorded May 5, 2021 (U.S. Bank National Association).
Term ends Feb 18, 2036 · High confidence
20-year base term ends Feb 18, 2036
Held by Jazz Pharma Ireland Limited
Filed Feb 18, 2016 as application 15/047,586 · Granted Sep 3, 2019
Base term, 20 years from filing
Today
2016
2036
Clock starts
Feb 18, 2016
Feb 18, 2016
Term ends
Feb 18, 2036
Feb 18, 2036
Granted
Sep 3, 2019
Sep 3, 2019
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 18, 2016, when this application, 15/047,586, was filed | Feb 18, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 18, 2036 | High confidence |
This family
| US 10,398,662 | this patent Feb 2036 | Feb 2036 |
| Application 16/448,598 | Abandoned not computed | not computed |
| US 11,077,079 | In force Feb 2036 | Feb 2036 |
| US 11,147,782 | In force Feb 2036 | Feb 2036 |
| US 11,364,215 | In force Feb 2036 | Feb 2036 |
| Application 17/838,527 | Abandoned not computed | not computed |
| Application 18/160,881 | Abandoned not computed | not computed |
| Application 18/473,935 | Abandoned not computed | not computed |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 5, 2016 Reel 39254, frame 453 | Jazz Pharmaceuticals, Inc.; Jazz Pharmaceuticals Ireland Limited | Bank of America, N.A., as Collateral Agent | Supplement No. 1 to Security Agreement |
| Nov 9, 2016 Reel 40270, frame 731 | Jazz Pharmaceuticals, Inc. | Jazz Pharma Ireland Limited | Assignment of Assignor's Interest |
| Nov 9, 2016 Reel 40270, frame 740 | Allphin, Clark; Bura, Scott | Jazz Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 6, 2020 Reel 52324, frame 40 | Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals Ireland Limited | Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 40270 Frame: 731. Assignor(S) Hereby Confirms the Assignment. |
| May 5, 2021 Reel 56151, frame 10 | Cavion, Inc.; Celator Pharmaceuticals, Inc.; Jazz Pharmaceuticals Ireland Limited; Jazz Pharmaceuticals, Inc. | U.S. Bank National Association | Security Agreement |
| May 5, 2021 Reel 56150, frame 708 | Bank Of America, N.a. | Jazz Pharmaceuticals, Inc.; Jazz Pharmaceuticals Ireland Limited; Jazz Pharmaceuticals International Limited; Jazz Pharmaceuticals International III Limited; Celator Pharmaceuticals, Inc.; Cavion, Inc. | Release of Security Interest |
| May 5, 2021 reel/frame not recorded | Bank Of America, N.a. | Jazz Pharmaceuticals, Inc. | Release of Security Interest |
| May 5, 2021 reel/frame not recorded | Bank Of America, N.a. | Jazz Pharmaceuticals Ireland Limited | Release of Security Interest |
| May 5, 2021 reel/frame not recorded | Bank Of America, N.a. | Jazz Pharmaceuticals International Limited | Release of Security Interest |
| May 5, 2021 reel/frame not recorded | Bank Of America, N.a. | Jazz Pharmaceuticals International III Limited | Release of Security Interest |
| May 5, 2021 reel/frame not recorded | Bank Of America, N.a. | Celator Pharmaceuticals, Inc. | Release of Security Interest |
| May 5, 2021 reel/frame not recorded | Bank Of America, N.a. | Cavion, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Feb 2036
Term ends Feb 18, 2036. Maintenance fees still fall due before then
Citations
60
later US patents cite this one
That is top 5% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.